GovChime
Notice ID: b4edba82212d4da6a258c458be450126Combined Synopsis/Solicitation

Ibandronate Sodium Tablets

Archived on November 6, 2025. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
3:00 PM UTC−04:00
Posted
October 6, 2025
Notice type
Combined Synopsis/Solicitation
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of WarDEFENSE LOGISTICS AGENCY

Notice details

Office
TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
PSC
6505: DRUGS AND BIOLOGICALS
Last updated
Dec 6, 2025

Identifiers

Solicitation number
SPE2D2-25-R-0019
Notice ID
b4edba82212d4da6a258c458be450126

Description

SPE2D2-25-R-0019 Ibandronate Sodium Tablets

Full description on SAM.gov

Award Overview

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Select documents to download

Showing 4 of 4 items

Document
Source
Agency
Posted Date
File Size
Actions
Combined Synopsis/SolicitationDEFENSE LOGISTICS AGENCYOct 6, 20251.33 MB
Combined Synopsis/SolicitationDEFENSE LOGISTICS AGENCYOct 6, 202517.97 KB
Combined Synopsis/SolicitationDEFENSE LOGISTICS AGENCYOct 6, 2025108.57 KB
Combined Synopsis/SolicitationDEFENSE LOGISTICS AGENCYOct 6, 2025106.95 KB

Lifecycle

Solicitation:SPE2D2-25-R-0019
  1. Combined Synopsis
  1. 2×
    Combined SynopsisCurrentSep 22, 2025

    Ibandronate Sodium Tablets

    Notice b4edba82212d4da6a258c458be450126 on SAM.gov

Similar Opportunities

Additional Details

Solicitation Number

SPE2D2-25-R-0019

Archive Date

Nov 6, 2025

Office Address

PHILADELPHIA, PA, 19111